Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

C Share Issue

16 Nov 2015 14:46

RNS Number : 8694F
Ranger Direct Lending Fund PLC
16 November 2015
 

 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member states of the European Economic Area (other than the United Kingdom), Canada, Australia, Japan or South Africa.

 

16 November 2015

 

Ranger Direct Lending Fund PLC

(the "Company")

C Share Issue

 

Further to the announcement made by the Company on 10 November 2015, the Company is pleased to announce that it has today published a prospectus (the "Prospectus") relating to a placing and intermediaries offer for a target issue of 13.5 million C Shares at a price of £10.00 per C Share to raise £135 million (the "Issue").1

 

The Company is also pleased to announce the commencement of the intermediaries offer ("Intermediaries Offer") today under which retail investors can apply for C Shares through stockbrokers and share dealing providers who are participating as intermediaries. The Intermediaries Offer closes at 5:00 p.m. on 24 November 2015. 

 

A list of the firms acting as intermediaries for the Intermediaries Offer, and a copy of the Prospectus, will shortly be available on the Company's website at www.RangerDirectLending.com. Copies of the Prospectus are also available free of charge during normal business hours from the Company's registered office, 40 Dukes Place, London EC3A 7NH.

 

The Prospectus has been submitted to the National Storage Mechanism and will shortly be available at http://www.hemscott.com/nsm.do.

 

http://rangerdirectlending.com/documents/

 

For further information, please contact:

 

Capita Company Secretarial Services Limited

Secretary

 

+44 (0)20 7954 9569

Ranger Capital Group Bill Kassul

Scott Canon

 

via Redleaf PR 

Liberum Capital Limited

Simon Atkinson

Tom Fyson

Joshua Hughes

 

+44 (0)20 3100 2000

Media enquiries

Redleaf Communications

Rebecca Sanders-Hewett

Richard Gotla

David Ison

Susie Hudson

 

ranger@redleafpr.com

+ 44 (0)20 7382 4731

Intermediary Offer enquiries:

Scott Harris

Jeremy Wiseman

Jamie Blewitt

+44 (0)20 7653 0030

 

Expected Timetable

 

2015

Latest time and date for receipt of completed application forms from the Intermediaries in respect of the Intermediaries Offer

 

5.00 p.m. on 24 November

 

Latest time and date for commitments under the Placing

 

12.00 p.m. on 25 November

Publication of results of the Issue

 

26 November

Admission and commencement of dealings in the C Shares issued under the Issue

 

8.00 a.m. on 30 November

CREST accounts credited in respect of uncertificated C Shares issued under the Issue

 

8.00 a.m. on 30 November

Where applicable, share certificates despatched in respect of C Shares issued under the Issue

 

Week commencing 14 December

Times and dates are subject to change.

 

 

 

Issue Statistics

 

Target size of the Placing and Intermediaries Offer

 

£135 million1

Issue price per C Share for the Issue

 

£10

Target estimated Net Proceeds receivable by the Company

 

£133 million

 

 

IMPORTANT INFORMATION

 

This announcement which has been prepared by, and is the sole responsibility of, the Directors of the Company has been approved solely for the purposes of section 21 of the Financial Services and Markets Act 2000 by Liberum Capital Limited ("Liberum"), which is authorised and regulated by the Financial Conduct Authority.

 

This announcement is an advertisement and does not constitute a prospectus relating to the Company and does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to subscribe for, any shares in the Company in any jurisdiction nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with or act as any inducement to enter into, any contract therefor. Copies of the prospectus published by the Company will be available from the Company's registered office.

 

Recipients of this announcement who are considering acquiring C Shares following publication of the prospectus are reminded that any such acquisition must be made only on the basis of the information contained in the prospectus which may be different from the information contained in this announcement. The subscription for C Shares is subject to specific legal or regulatory restrictions in certain jurisdictions. Persons distributing this announcement must satisfy themselves that it is lawful to do so. The Company assumes no responsibility in the event that there is a violation by any person of such restrictions.

 

This document may not be published, distributed or transmitted by any means or media, directly or indirectly, in whole or in part, in or into the United States. This document does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States. The securities mentioned herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "US Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States and will not be offered, sold, exercised, resold, transferred or delivered, directly or indirectly, in or into the United States or to, or for the account or benefit of, any US person (as defined under Regulation S under the US Securities Act). The Company has not been, and will not be, registered under the U.S. Investment Company Act of 1940, as amended.

 

Neither this announcement nor any copy of it may be: (i) taken or transmitted into or distributed in any member state of the European Economic Area (other than the United Kingdom), Canada, Australia or the Republic of South Africa or to any resident thereof, or (ii) taken or transmitted into or distributed in Japan or to any resident thereof. Any failure to comply with these restrictions may constitute a violation of the securities laws or the laws of any such jurisdiction. The distribution of this announcement in other jurisdictions may be restricted by law and the persons into whose possession this document comes should inform themselves about, and observe, any such restrictions.

 

This announcement may include "forward-looking statements". All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to the Company's products and services) are forward-looking statements.

 

Forward-looking statements are subject to risks and uncertainties and accordingly the Company's actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These factors include but are not limited to those described in the formal prospectus. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

 

Liberum, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting only for the Company in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Liberum or advice to any other person in relation to the matters contained herein. Neither Liberum nor any of its directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of, the information in this announcement (or whether any information has been omitted from the announcement) or any information relating to the Company, whether written, oral or in a visual or electronic format, and howsoever transmitted or made available or any loss howsoever arising from any use of this announcement or its contents or otherwise in connection with it.

 

1The Directors have reserved the right, in consultation with Liberum, to increase the size of the Issue to up to 16.5 million C Shares if overall demand exceeds 13.5 million C Shares, with any such increase being announced through a Regulatory Information Service.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBSBDBSSBBGUL
Date   Source Headline
25th Jan 202111:50 amRNSPortfolio Update
12th Jan 20211:12 pmRNSResult of General Meeting
23rd Dec 20207:00 amRNSPortfolio Update
21st Dec 20204:59 pmRNSPublication of Delisting Circular and Notice of GM
21st Dec 20204:59 pmRNSHolding(s) in Company
10th Dec 20205:20 pmRNSDividend Declaration
27th Nov 20205:37 pmRNSHolding(s) in Company
25th Nov 20207:00 amRNSChange of AIFM and intention to delist
24th Nov 202010:31 amRNSPortfolio Update
26th Oct 20209:56 amRNSPortfolio Update
23rd Oct 20204:41 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:36 pmRNSPrice Monitoring Extension
12th Oct 20207:00 amRNSPortfolio Update
22nd Sep 20207:00 amRNSHalf-year Report
16th Sep 20204:34 pmRNSDirector Declaration
9th Sep 202012:31 pmRNSPortfolio Update
20th Aug 202012:07 pmRNSSecond Price Monitoring Extn
20th Aug 202012:02 pmRNSPrice Monitoring Extension
22nd Jul 20209:43 amRNSPortfolio Update
9th Jul 202011:16 amRNSDirector Declaration
30th Jun 20203:37 pmRNSResult of AGM
24th Jun 20202:48 pmRNSPortfolio Update
8th Jun 20204:41 pmRNSSecond Price Monitoring Extn
8th Jun 20204:35 pmRNSPrice Monitoring Extension
4th Jun 20207:00 amRNSAnnual Financial Report
28th May 20206:00 pmRNSRevised Publication Date For The Annual Report
15th May 20204:40 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
4th May 202011:21 amRNSPortfolio Update
30th Apr 20202:41 pmRNSPublication Date for Annual Report
27th Apr 20209:58 amRNSDisclosure of Rights Attaching to Equity Shares
7th Apr 20207:00 amRNSDividend Declaration
2nd Apr 202010:54 amRNSResignation of Director
30th Mar 20202:02 pmRNSPortfolio Update
16th Mar 20207:00 amRNSPrinceton Update
11th Mar 20207:00 amRNSPortfolio Update
20th Feb 20205:06 pmRNSPrinceton Update
3rd Feb 20207:00 amRNSPortfolio Update
17th Jan 20209:44 amRNSHolding(s) in Company
10th Jan 20204:41 pmRNSPrinceton Update
9th Jan 202012:11 pmRNSDividend Declaration
31st Dec 201911:18 amRNSUpdate - Standstill Agreement
24th Dec 201910:11 amRNSHolding(s) in Company
23rd Dec 20194:49 pmRNSPortfolio Update
10th Dec 201910:12 amRNSDirector Declaration
26th Nov 201911:29 amRNSPortfolio Update
26th Nov 20197:00 amRNSDividend Declaration
6th Nov 201910:07 amRNSPortfolio Update
28th Oct 20194:50 pmRNSDirector Declaration
24th Oct 201911:21 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.